Whole Genome Sequencing (WGS) is a technology that utilizes high-throughput sequencing platforms to sequence the entire genome of different individuals or populations of humans and perform bioinformatics analysis at the individual or population level. This sequencing technology can comprehensively explore genetic variations at the DNA level, including larger structural variations, providing important information for screening disease pathogenic and susceptible genes, studying disease onset and genetic mechanisms, and inferring population migration and evolution.
Analysis of Market Driving Factors
|
Technological progress |
With the continuous development of sequencing technology, especially the popularization of Next Generation Sequencing (NGS) technology, the cost of whole genome sequencing continues to decrease, while efficiency and quality continue to improve. This enables more laboratories and medical institutions to perform whole genome sequencing. |
|
Policy promotion |
Multiple countries and regions around the world are promoting the development of genomics research and applications, including providing financial support and formulating industry standards. These policies help drive the growth of the whole genome sequencing market. |
|
Market demand |
With the increasing public attention to health and genetic information, more and more people are willing to conduct whole genome sequencing to understand their own health status and genetic risks. At the same time, research institutions, hospitals, and pharmaceutical companies also have a high demand for whole genome sequencing for disease research, drug development, and personalized treatment. |
We provide more professional and intelligent market reports to complement your business decisions.
Chinese